The Irish Medicines Verification Organisation (IMVO) recently announced the appointment of Paul Reid as Independent Chair of its Board.
Mr Reid brings extensive leadership experience across the public, private and not-for-profit sectors. He previously served as CEO of the Health Service Executive (HSE) from May 2019 to December 2022, where he led Ireland’s health service through the Covid-19 global pandemic and a significant criminal cyber-attack, while acting as a key advisor to Government and communicator to the public.
With deep expertise as a board chairperson, non-executive director and CEO, he is currently Chair of An Coimisiún Pleanála, Ireland’s national and independent planning authority, and Chair of Ashdale Care, a sector leader in the provision of specialist residential care services for children and young people.
Commenting on his appointment, Mr Reid said: “I’m delighted to be joining the board of IMVO as Chair. The organisation plays a key role in protecting the public and patients, which is something that I’m highly committed to.”
Leonie Clarke, Chief Executive of IMVO, welcomed the appointment, saying:
“We are delighted to welcome Paul as Independent Chair of IMVO. His depth of experience, knowledge of healthcare in Ireland and unwavering commitment to public service will be invaluable as we work towards our vision of a secure and sustainable medicines supply chain where patients are confident about the authenticity of prescription medicines they receive in the Irish healthcare system.”
Mr Reid succeeds Prof Pat O’Mahony, who served as Independent Chair from June 2017 until his unexpected passing in August 2025.
